Rhenman & Partners Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-175,000	Closed	-$7.62M	–	100
2023 Q3	$7.62M	Buy	175,000 +35,000	+25%	+$1.52M	0.82%	41
2023 Q2	$5.06M	Sell	140,000 -75,000	-35%	-$2.71M	0.53%	56
2023 Q1	$7.89M	Sell	215,000 -85,000	-28%	-$3.12M	0.87%	37
2022 Q4	$13.6M	Buy	300,000 +102,933	+52%	+$4.66M	1.42%	29
2022 Q3	$13.3M	Buy	197,067 +7,067	+4%	+$476K	1.39%	29
2022 Q2	$12.8M	Buy	190,000 +40,200	+27%	+$2.7M	1.45%	27
2022 Q1	$12.3M	Sell	149,800 -200	-0.1%	-$16.4K	1.22%	33
2021 Q4	$22.2M	Hold	150,000	–	–	1.48%	24
2021 Q3	$26.5M	Sell	150,000 -15,000	-9%	-$2.65M	1.86%	15
2021 Q2	$26.7M	Buy	165,000 +15,000	+10%	+$2.42M	1.81%	14
2021 Q1	$25.7M	Buy	150,000 +50,000	+50%	+$8.57M	1.79%	19
2020 Q4	$22M	Sell	100,000 -14,311	-13%	-$3.14M	1.79%	18
2020 Q3	$19M	Buy	114,311 +14,311	+14%	+$2.38M	1.69%	22
2020 Q2	$11.4M	Sell	100,000 -30,000	-23%	-$3.43M	1.23%	34
2020 Q1	$9.99M	Buy	130,000 +5,000	+4%	+$384K	1.4%	30
2019 Q4	$16.1M	Buy	125,000 +25,000	+25%	+$3.22M	1.77%	17
2019 Q3	$7.79M	Sell	100,000 -82,008	-45%	-$6.39M	0.98%	42
2019 Q2	$18.7M	Buy	182,008 +54,915	+43%	+$5.66M	2.07%	15
2019 Q1	$9.32M	Buy	127,093 +42,093	+50%	+$3.09M	1.09%	37
2018 Q4	$3.61M	Buy	+85,000	New	+$3.61M	0.41%	63
2017 Q3	–	Sell	-50,000	Closed	-$183K	–	109
2017 Q2	$183K	Hold	50,000	–	–	0.03%	105
2017 Q1	$260K	Hold	50,000	–	–	0.04%	101
2016 Q4	$238K	Hold	50,000	–	–	0.05%	102
2016 Q3	$331K	Hold	50,000	–	–	0.05%	94
2016 Q2	$273K	Hold	50,000	–	–	0.05%	94
2016 Q1	$1.07M	Hold	50,000	–	–	0.21%	87
2015 Q4	$1.58M	Hold	50,000	–	–	0.24%	88
2015 Q3	$1.72M	Hold	50,000	–	–	0.27%	82
2015 Q2	$1.57M	Buy	50,000 +4,612	+10%	+$145K	0.19%	90
2015 Q1	$1.33M	Buy	+45,388	New	+$1.33M	0.22%	85